We are delighted to share that Dr. Poulomi Banerjee, Principal Scientist at SKAN Research Trust, has been invited to speak at ICTN 2026 – International Conference on Translational Neuroscience, taking place at CUSAT, Kochi, from 14–16 September 2026.
Link to the conference website:
About SKAN Research Trust
SKAN is a Bengaluru-based not-for-profit medical research trust focussed on transformational technologies that will alter the future of medicine through the discovery of new therapies. SKAN’s areas of expertise include human genomics, stem cells, gut microbiome, molecular biology, and transformational artificial intelligence applied to areas of ageing and neurological ailments to achieve breakthrough therapies.
OPEN Autism: A Concept to Explore Neurobiology
About SKAN Research Trust
SKAN is a Bengaluru-based not-for-profit medical research trust focussed on transformational technologies that will alter the future of medicine through the discovery of new therapies. SKAN’s areas of expertise include human genomics, stem cells, gut microbiome, molecular biology, and transformational artificial intelligence applied to areas of ageing and neurological ailments to achieve breakthrough therapies.
Clonal hematopoiesis of indeterminate potential (CHIP)—a pivotal contributor of aging and related disorders. Authors – Ankita Dhenge, Rohan Kulkarni.
Journal – Annals of Translational Medicine
Aging is accompanied by a progressive decline in organ and tissue function, increasing the risk of chronic diseases and mortality. Among the emerging hallmarks of aging, clonal hematopoiesis of indeterminate potential (CHIP) has gained considerable attention as a key age-associated condition linked to cardiovascular, neurological, and other inflammatory disorders.
In this comprehensive review, we discuss the intrinsic and extrinsic changes in the hematopoietic system that drive age-related clonal expansion and the development of CHIP. We further examine the growing evidence connecting CHIP with diverse disease states, summarize the current diagnostic approaches and management strategies, and highlight the global landscape of CHIP research.
As CHIP-centered research continues to evolve, a deeper understanding of its biology and clinical implications may pave the way for novel therapeutic interventions aimed at preventing CHIP progression and mitigating the burden of age-related diseases.
View Publication (Publication Date – 11th May 2026)
About SKAN Research Trust
SKAN is a Bengaluru-based not-for-profit medical research trust focussed on transformational technologies that will alter the future of medicine through the discovery of new therapies. SKAN’s areas of expertise include human genomics, stem cells, gut microbiome, molecular biology, and transformational artificial intelligence applied to areas of ageing and neurological ailments to achieve breakthrough therapies.